Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Montefiore Medical Center.
Recruitment status was  Recruiting
Eli Lilly and Company
OSI Pharmaceuticals
Information provided by:
Montefiore Medical Center Identifier:
First received: July 30, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)